[
  {"target_name": "mRNA技術がノーベル賞受賞（2023）","scale": "other","period": "2023","story_summary": "mRNAワクチン技術の開発者がノーベル生理学・医学賞を受賞。","before_state": "拡大・繁栄","trigger_type": "自然推移","action_type": "輝く・表現","after_state": "拡大・繁栄","before_hex": "乾","trigger_hex": "離","action_hex": "離","after_hex": "震","pattern_type": "Breakthrough","outcome": "Success","free_tags": ["#mRNA", "#ノーベル賞", "#医学"],"source_type": "news","credibility_rank": "A","changing_lines_1": [1, 4],"changing_lines_2": [2, 5],"changing_lines_3": [3, 6],"country": "アメリカ","main_domain": "テクノロジー","sources": ["https://www.nobelprize.org/"],"confidence_percent": 95,"evidence_notes": "mRNAワクチン技術開発者ノーベル生理学・医学賞受賞","logic_memo": "乾（成功）→離（評価）→離（受賞）→震（世界的認知）。科学の勝利"},
  {"target_name": "アルツハイマー新薬承認で医療革新（2023）","scale": "other","period": "2023","story_summary": "アルツハイマー病治療薬レカネマブが日米で承認された。","before_state": "混乱・衰退","trigger_type": "外部ショック","action_type": "分散・探索","after_state": "拡大・繁栄","before_hex": "坎","trigger_hex": "震","action_hex": "巽","after_hex": "震","pattern_type": "Breakthrough","outcome": "Success","free_tags": ["#アルツハイマー", "#新薬", "#認知症"],"source_type": "news","credibility_rank": "A","changing_lines_1": [2, 5],"changing_lines_2": [3, 6],"changing_lines_3": [1, 4],"country": "日本","main_domain": "医療・製薬","sources": ["https://www.pmda.go.jp/"],"confidence_percent": 90,"evidence_notes": "アルツハイマー病治療薬レカネマブ日米で承認","logic_memo": "坎（難病）→震（承認）→巽（普及）→震（医療革新）。認知症治療の突破口"},
  {"target_name": "量子コンピュータ実用化進む（2023-2024）","scale": "other","period": "2023-2024","story_summary": "量子コンピュータの実用化が進み、産業界での活用が始まった。","before_state": "安定・停止","trigger_type": "外部ショック","action_type": "分散・探索","after_state": "拡大・繁栄","before_hex": "艮","trigger_hex": "震","action_hex": "巽","after_hex": "震","pattern_type": "Breakthrough","outcome": "Success","free_tags": ["#量子コンピュータ", "#実用化", "#テクノロジー"],"source_type": "news","credibility_rank": "A","changing_lines_1": [1, 4],"changing_lines_2": [2, 5],"changing_lines_3": [3, 6],"country": "アメリカ","main_domain": "テクノロジー","sources": ["https://www.ibm.com/"],"confidence_percent": 85,"evidence_notes": "量子コンピュータ実用化進み産業界での活用始まった","logic_memo": "艮（研究）→震（実用化）→巽（活用）→震（産業変革）。次世代計算の幕開け"},
  {"target_name": "核融合発電で大きな進展（2022-2024）","scale": "other","period": "2022-2024","story_summary": "核融合発電の研究で大きな進展があり、実用化への期待が高まった。","before_state": "安定・停止","trigger_type": "外部ショック","action_type": "集中・拡大","after_state": "拡大・繁栄","before_hex": "艮","trigger_hex": "震","action_hex": "乾","after_hex": "震","pattern_type": "Breakthrough","outcome": "Success","free_tags": ["#核融合", "#エネルギー", "#研究"],"source_type": "news","credibility_rank": "A","changing_lines_1": [2, 5],"changing_lines_2": [3, 6],"changing_lines_3": [1, 4],"country": "アメリカ","main_domain": "エネルギー・環境","sources": ["https://www.energy.gov/"],"confidence_percent": 85,"evidence_notes": "核融合発電研究で大きな進展があり実用化期待高まった","logic_memo": "艮（研究）→震（ブレークスルー）→乾（投資）→震（期待）。夢のエネルギー"},
  {"target_name": "宇宙ビジネス民間参入加速（2022-2024）","scale": "other","period": "2022-2024","story_summary": "民間企業の宇宙ビジネス参入が加速し、市場が急成長した。","before_state": "安定・停止","trigger_type": "外部ショック","action_type": "集中・拡大","after_state": "拡大・繁栄","before_hex": "艮","trigger_hex": "震","action_hex": "乾","after_hex": "震","pattern_type": "Breakthrough","outcome": "Success","free_tags": ["#宇宙ビジネス", "#民間", "#SpaceX"],"source_type": "news","credibility_rank": "A","changing_lines_1": [1, 4],"changing_lines_2": [2, 5],"changing_lines_3": [3, 6],"country": "アメリカ","main_domain": "テクノロジー","sources": ["https://www.spacex.com/"],"confidence_percent": 90,"evidence_notes": "民間企業宇宙ビジネス参入加速し市場急成長","logic_memo": "艮（政府主導）→震（民間参入）→乾（拡大）→震（市場急成長）。宇宙の民主化"},
  {"target_name": "CRISPR遺伝子治療承認（2023）","scale": "other","period": "2023","story_summary": "CRISPR技術を使った遺伝子治療が世界で初めて承認された。","before_state": "安定・停止","trigger_type": "外部ショック","action_type": "分散・探索","after_state": "拡大・繁栄","before_hex": "艮","trigger_hex": "震","action_hex": "巽","after_hex": "震","pattern_type": "Breakthrough","outcome": "Success","free_tags": ["#CRISPR", "#遺伝子治療", "#承認"],"source_type": "news","credibility_rank": "A","changing_lines_1": [2, 5],"changing_lines_2": [3, 6],"changing_lines_3": [1, 4],"country": "イギリス","main_domain": "医療・製薬","sources": ["https://www.fda.gov/"],"confidence_percent": 90,"evidence_notes": "CRISPR技術使った遺伝子治療世界初承認","logic_memo": "艮（研究）→震（承認）→巽（普及）→震（医療革命）。遺伝子編集の夜明け"},
  {"target_name": "AIチップ競争激化（2023-2024）","scale": "other","period": "2023-2024","story_summary": "AI向け半導体チップの開発競争が世界規模で激化した。","before_state": "拡大・繁栄","trigger_type": "外部ショック","action_type": "集中・拡大","after_state": "拡大・繁栄","before_hex": "乾","trigger_hex": "震","action_hex": "乾","after_hex": "震","pattern_type": "Breakthrough","outcome": "Success","free_tags": ["#AIチップ", "#半導体", "#競争"],"source_type": "news","credibility_rank": "A","changing_lines_1": [1, 4],"changing_lines_2": [2, 5],"changing_lines_3": [3, 6],"country": "アメリカ","main_domain": "テクノロジー","sources": ["https://www.nvidia.com/"],"confidence_percent": 90,"evidence_notes": "AI向け半導体チップ開発競争世界規模で激化","logic_memo": "乾（成長）→震（AI需要）→乾（投資）→震（競争激化）。半導体戦争"},
  {"target_name": "ロボット技術で介護革新（2023-2024）","scale": "other","period": "2023-2024","story_summary": "介護ロボットの導入が進み、人手不足対策として注目された。","before_state": "混乱・衰退","trigger_type": "外部ショック","action_type": "分散・探索","after_state": "拡大・繁栄","before_hex": "坎","trigger_hex": "震","action_hex": "巽","after_hex": "震","pattern_type": "Crisis_Pivot","outcome": "Success","free_tags": ["#介護ロボット", "#人手不足", "#テクノロジー"],"source_type": "news","credibility_rank": "A","changing_lines_1": [2, 5],"changing_lines_2": [3, 6],"changing_lines_3": [1, 4],"country": "日本","main_domain": "テクノロジー","sources": ["https://www.meti.go.jp/"],"confidence_percent": 85,"evidence_notes": "介護ロボット導入進み人手不足対策として注目","logic_memo": "坎（人手不足）→震（導入）→巽（活用）→震（革新）。テクノロジーの福祉"},
  {"target_name": "次世代バッテリー技術進展（2023-2024）","scale": "other","period": "2023-2024","story_summary": "全固体電池などの次世代バッテリー技術が大きく進展した。","before_state": "安定・停止","trigger_type": "外部ショック","action_type": "集中・拡大","after_state": "拡大・繁栄","before_hex": "艮","trigger_hex": "震","action_hex": "乾","after_hex": "震","pattern_type": "Breakthrough","outcome": "Success","free_tags": ["#全固体電池", "#バッテリー", "#EV"],"source_type": "news","credibility_rank": "A","changing_lines_1": [1, 4],"changing_lines_2": [2, 5],"changing_lines_3": [3, 6],"country": "日本","main_domain": "テクノロジー","sources": ["https://www.toyota.co.jp/"],"confidence_percent": 85,"evidence_notes": "全固体電池など次世代バッテリー技術大きく進展","logic_memo": "艮（研究）→震（進展）→乾（投資）→震（期待）。EV革命の鍵"},
  {"target_name": "6G通信規格策定開始（2024）","scale": "other","period": "2024","story_summary": "6G通信規格の策定が世界で本格的に始まった。","before_state": "安定・停止","trigger_type": "自然推移","action_type": "分散・探索","after_state": "拡大・繁栄","before_hex": "艮","trigger_hex": "巽","action_hex": "巽","after_hex": "震","pattern_type": "Breakthrough","outcome": "Success","free_tags": ["#6G", "#通信", "#規格"],"source_type": "news","credibility_rank": "A","changing_lines_1": [2, 5],"changing_lines_2": [3, 6],"changing_lines_3": [1, 4],"country": "日本","main_domain": "テクノロジー","sources": ["https://www.soumu.go.jp/"],"confidence_percent": 85,"evidence_notes": "6G通信規格策定世界で本格的に始まった","logic_memo": "艮（5G）→巽（検討）→巽（策定）→震（次世代へ）。通信の未来"}
]
